These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9096591)

  • 21. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
    Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation.
    Braun L; Mikumo R; Fausto N
    Cancer Res; 1989 Mar; 49(6):1554-61. PubMed ID: 2647288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP.
    Columbano A; Ledda-Columbano GM; Pibiri M; Piga R; Shinozuka H; De Luca V; Cerignoli F; Tripodi M
    Oncogene; 1997 Feb; 14(7):857-63. PubMed ID: 9047393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
    Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.
    Shiota G; Wang TC; Nakamura T; Schmidt EV
    Hepatology; 1994 Apr; 19(4):962-72. PubMed ID: 8138271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
    d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
    Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL; Chisari FV; Merlino G
    Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
    Mulder KM
    Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
    Cheung RS; Brooling JT; Johnson MM; Riehle KJ; Campbell JS; Fausto N
    Carcinogenesis; 2007 Dec; 28(12):2624-31. PubMed ID: 17698969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.